358,45 €
1,61 %
L&S, 24. Juni, 12:30 Uhr. Markt geöffnet.
ISIN
CH1499059983
Symbol
ROP
Index

Roche Aktie News

Negativ
WSJ
vor 5 Tagen
The investigation comes after Berlin said it would require drugmakers to offer bigger discounts on medicines.
Negativ
CNBC
vor 5 Tagen
The U.S. said the probe will examine whether "persistent underpayment" for medicines by Germany is discriminatory. "President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development," said U.S. Trade Representative Jamieson Greer.
Negativ
Reuters
vor 6 Tagen
The U.S. Food and Drug Administration approved the first generic version of ​Roche's Xofluza, a single-dose flu medicine for ‌certain patients aged five years and older, the regulator said on Wednesday.
Neutral
CNBC
vor 11 Tagen
Eli Lilly, Novo Nordisk, Amgen, Zealand, Structure Therapeutics shared their visions for the future of obesity medicine. Drugmakers pitched doctors and investors on their future drugs at the recent American Diabetes Association (ADA) Scientific Sessions in New Orleans.
Positiv
Seeking Alpha
vor 13 Tagen
Recently, Nurix secured a partnership with Roche, which I believe has substantially derisked the stock as a whole. Similarly, this deal helps validate NRIX's bexobrutideg and its potential as a broader platform in the long term. NRIX's bexobrutideg is easily their main value driver, and after NRIX's recent equity raises and deal with Roche, it looks like they should have enough runway for the f...
Neutral
Seeking Alpha
vor 14 Tagen
Roche Holding AG and Pfizer Inc. are aggressively advancing obesity and T2D pipelines to capture share in the surging GLP-1 market. RHHBY's enicepatide shows strong Phase 2 weight loss data (22.7% at 24mg), with a robust safety profile and a diversified cardiometabolic pipeline. PFE touts monthly-dosed berobenatide as potentially best-in-class via meta-analysis, but lacks head-to-head clinical ...
Positiv
Reuters
vor 15 Tagen
The Swiss pharmaceutical and diagnostics giant Roche said it is sticking to its ​planned investments in Germany, unlike some of ‌its competitors that have scaled back spending in the country.
Positiv
Barrons
vor 16 Tagen
Nurix Therapeutics strikes an agreement with Roche to commercialize its lead asset, bexobrutideg.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen